Take-home naloxone: a building block of drug emergency prophylaxis in Germany

被引:0
|
作者
Fleissner, Simon [1 ]
Stoever, Heino [1 ]
Schaeffer, Dirk [2 ]
机构
[1] Univ Appl Sci Frankfurt, Inst Suchtforsch Frankfurt ISFF, Frankfurt, Germany
[2] Deutsch Aidshilfe EV, Berlin, Germany
关键词
Harm reduction; Opioid overdose; Naloxone Nasal Spray; Mortality prophylaxis; Drug-induced death; OVERDOSE; ASSOCIATION; DEATHS;
D O I
10.1007/s00103-023-03705-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Naloxone is an opioid antagonist that reverses the (respiratory-paralyzing) effects of opioids in the body within minutes. Naloxone can therefore reduce opioid overdose deaths. Take-home naloxone (THN) is an intervention recommended by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the World Health Organization (WHO). It involves training opioid users and their relatives or friends in the use of naloxone and providing them with the drug in case of emergency.So far, THN has been implemented in Germany mainly by individual addiction support facilities. In order to fully exploit the potential of THN, it is necessary to establish the measure nationwide. In particular, THN can be included in the services offered in (low-threshold) addiction support facilities, in psychiatric facilities, in the context of opioid substitution treatment, and in the correctional system.This discussion article reviews the development of THN in Germany since 1998, highlights the difficulties and obstacles to its widespread implementation, and outlines how THN can succeed as an effective public health intervention in Germany. This is particularly relevant in view of the increasing number of drug-related deaths over the past 10 years.
引用
收藏
页码:1035 / 1041
页数:7
相关论文
共 50 条
  • [31] Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine
    John Strang
    Rebecca McDonald
    Gabrielle Campbell
    Louisa Degenhardt
    Suzanne Nielsen
    Alison Ritter
    Ola Dale
    [J]. Drugs, 2019, 79 : 1395 - 1418
  • [32] Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine
    Strang, John
    McDonald, Rebecca
    Campbell, Gabrielle
    Degenhardt, Louisa
    Nielsen, Suzanne
    Ritter, Alison
    Dale, Ola
    [J]. DRUGS, 2019, 79 (13) : 1395 - 1418
  • [33] Implementing take-home naloxone in an urban community pharmacy
    Akers, Joshua L.
    Hansen, Ryan N.
    Oftebro, Ryan D.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2017, 57 (02) : S161 - S167
  • [34] Take-home naloxone: a life saver in opioid overdose
    不详
    [J]. LANCET, 2019, 393 (10169): : 296 - 296
  • [35] Opioid Prescribing with Take-Home Naloxone: Rationale and Recommendations
    Jaya Amaram-Davila
    Tarun Mallipeddi
    Akhila Reddy
    [J]. Current Anesthesiology Reports, 2020, 10 : 428 - 435
  • [36] Who is using take-home naloxone? An examination of supersavers
    Desiree Eide
    Philipp Lobmaier
    Thomas Clausen
    [J]. Harm Reduction Journal, 19
  • [37] Managing opioid overdose in pregnancy with take-home naloxone
    Blandthorn, Julie
    Bowman, Ellen
    Leung, Laura
    Bonomo, Yvonne
    Dietze, Paul
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2018, 58 (04): : 460 - 462
  • [38] Take-home naloxone and paramedicine: An opportunity for harm minimisation
    Waddell, Jason J.
    Parker, Lachlan E.
    Ansell, Chelsea
    [J]. EMERGENCY MEDICINE AUSTRALASIA, 2022, 34 (06) : 1030 - 1030
  • [39] Take-home Naloxone at Opioid Treatment Programs: A Lifesaver
    Katzman, Joanna G.
    Bhatt, Snehal
    Comerci, George D. Jr Jr
    [J]. JOURNAL OF ADDICTION MEDICINE, 2022, 16 (06) : E417 - E419
  • [40] Who is using take-home naloxone? An examination of supersavers
    Eide, Desiree
    Lobmaier, Philipp
    Clausen, Thomas
    [J]. HARM REDUCTION JOURNAL, 2022, 19 (01)